MRSA surveillance programmes worldwide: moving towards a harmonised international approach
Language English Country Netherlands Media print-electronic
Document type Journal Article
Grant support
MR/P028322/1
Medical Research Council - United Kingdom
PubMed
35091055
DOI
10.1016/j.ijantimicag.2022.106538
PII: S0924-8579(22)00028-0
Knihovny.cz E-resources
- Keywords
- Antimicrobial resistance, Epidemiology, Monitoring, Staphylococcus aureus,
- MeSH
- Anti-Bacterial Agents pharmacology therapeutic use MeSH
- Epidemiological Monitoring MeSH
- Soft Tissue Infections * drug therapy MeSH
- Humans MeSH
- Methicillin-Resistant Staphylococcus aureus * MeSH
- Staphylococcal Infections * drug therapy MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
Multinational surveillance programmes for methicillin-resistant Staphylococcus aureus (MRSA) are dependent on national structures for data collection. This study aimed to capture the diversity of national MRSA surveillance programmes and to propose a framework for harmonisation of MRSA surveillance. The International Society of Antimicrobial Chemotherapy (ISAC) MRSA Working Group conducted a structured survey on MRSA surveillance programmes and organised a webinar to discuss the programmes' strengths and challenges as well as guidelines for harmonisation. Completed surveys represented 24 MRSA surveillance programmes in 16 countries. Several countries reported separate epidemiological and microbiological surveillance. Informing clinicians and national policy-makers were the most common purposes of surveillance. Surveillance of bloodstream infections (BSIs) was present in all programmes. Other invasive infections were often included. Three countries reported active surveillance of MRSA carriage. Methodology and reporting of antimicrobial susceptibility, virulence factors, molecular genotyping and epidemiological metadata varied greatly. Current MRSA surveillance programmes rely upon heterogeneous data collection systems, which hampers international epidemiological monitoring and research. To harmonise MRSA surveillance, we suggest improving the integration of microbiological and epidemiological data, implementation of central biobanks for MRSA isolate collection, and inclusion of a representative sample of skin and soft-tissue infection cases in addition to all BSI cases.
Department of Epidemiology and Clinical Microbiology National Medicines Institute Warsaw Poland
Department of Infection Control Mater Dei Hospital Msida Malta
Department of Medicine University of Pennsylvania Philadelphia Pennsylvania USA
Department of Microbiology LHUB ULB Université Libre de Bruxelles Brussels Belgium
East Tallinn Central Hospital Laboratory Tallinn Estonia
Healthcare associated infections and antimicrobial resistance Sciensano Brussels Belgium
Institute for Infection and Immunity St George's University of London London UK
Institute for Medical Microbiology Immunology and Hygiene University of Cologne Köln Germany
Mission nationale SPARES Limoges University Hospital Limoges France
National Infection Service Public Health England London UK
National MRSA Reference Laboratory St James's Hospital Dublin 8 Ireland
The Norwegian MRSA Reference Laboratory St Olavs Hospital Trondheim Norway
References provided by Crossref.org